JY
RXII

Jeff Yass’s GALENA BIOPHARMA INC COM RXII Stock Holding History

Jeff Yass’s Portfolio RXII Stock Details RXII Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-535,907
Closed -$188K – 10657
2016
Q3 		$188K Sell
535,907
-270,449
-34% -$94.9K ﹤0.01% 7627
2016
Q2 		$376K Buy
806,356
+133,103
+20% +$62.1K ﹤0.01% 6602
2016
Q1 		$916K Buy
673,253
+164,806
+32% +$224K ﹤0.01% 5271
2015
Q4 		$747K Sell
508,447
-255,906
-33% -$376K ﹤0.01% 6011
2015
Q3 		$1.21M Sell
764,353
-231,444
-23% -$366K ﹤0.01% 5294
2015
Q2 		$1.69M Buy
995,797
+175,212
+21% +$298K ﹤0.01% 5073
2015
Q1 		$1.14M Sell
820,585
-79,020
-9% -$110K ﹤0.01% 5482
2014
Q4 		$1.36M Buy
899,605
+193,544
+27% +$292K ﹤0.01% 5250
2014
Q3 		$1.45M Buy
706,061
+125,455
+22% +$258K ﹤0.01% 5196
2014
Q2 		$1.78M Buy
580,606
+501,575
+635% +$1.53M ﹤0.01% 4888
2014
Q1 		$197K Sell
79,031
-70,413
-47% -$176K ﹤0.01% 8253
2013
Q4 		$741K Sell
149,444
-59,275
-28% -$294K ﹤0.01% 6035
2013
Q3 		$474K Buy
+208,719
New +$474K ﹤0.01% 6512

Jeff Yass's RXII Position: Q4 2016 in Review

Jeff Yass sold out of GALENA BIOPHARMA INC COM (RXII) in Q4 2016, closing a stake of 535,907 shares — an estimated $188K sold.

Jeff Yass first reported a position in RXII in Q3 2013 and held it in 13 quarters. The position peaked at $1.78M in Q2 2014. 0 funds tracked by Wall St. Rank hold RXII as of Q4 2016.

  • Jeff Yass reported no remaining GALENA BIOPHARMA INC COM position as of Q4 2016 after selling out during the quarter.
  • Jeff Yass sold 535,907 GALENA BIOPHARMA INC COM shares in Q4 2016, an estimated $188K.
  • Jeff Yass first reported a position in GALENA BIOPHARMA INC COM in Q3 2013 and held it in 13 quarters.
  • Jeff Yass's GALENA BIOPHARMA INC COM position peaked at $1.78M in Q2 2014.
  • 0 funds tracked by Wall St. Rank held GALENA BIOPHARMA INC COM as of Q4 2016.

Based on Susquehanna International Group's 13F filing for Q4 2016, filed 14 Feb 2017.